Berger Mark Stanley
Known title: Chief Medical OfficerCIK: 0001700283
Associated companies
Transaction History
| GNPX | ▼ Sell | Tax Withholding | 7,168 | $14K | 2/27/2026 | View on chart |
| GNPX | ▲ Buy | Grant | 28,500 | $0 | 12/22/2025 | View on chart |
| GNPX | ▼ Sell | Tax Withholding | 4,500 | $1K | 6/30/2025 | View on chart |
| GNPX | ▼ Sell | Tax Withholding | 585 | $240 | 2/18/2025 | View on chart |
| GNPX | ▲ Buy | Grant | 18,250 | $0 | 12/5/2024 | View on chart |
| GNPX | ▼ Sell | Tax Withholding | 1,319 | $6K | 2/18/2024 | View on chart |
| GNPX | ▲ Buy | Grant | 245,000 | $0 | 2/18/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
GNPX Among Top Movers in Monday After-Hours Session
Genprex (GNPX) was listed among the top gainers and losers in Monday's after-hours trading, according to market trackers. This movement places the stock in focus within the broader health care sector's post-market activity. The company's stock is currently trading near its 52-week low, with technical indicators showing oversold conditions.
GNPX Among Top Movers in Monday After-Hours Session. Genprex (GNPX) was listed among the top gainers and losers in Monday's after-hours trading, according to market trackers. This movement places the stock in focus within the broader health care sector's post-market activity. The company's stock is currently trading near its 52-week low, with technical indicators showing oversold conditions.